The genomic studies of familial cases of Wilms tumor have allowed the identification of germline variants in the DICER1, WT1 (WT1 Transcription Factor), CHEK2 (Checkpoint Kinase 2), and PALB2 (Partner And Localizer Of BRCA2) genes [46,79,80]. This evidence concerns the gene CHEK2 and Wilms tumor.